Rifamycin S is an antibiotic against Gram-positive bacteria (including MRSA). It is involved in the oxidation form of two electron reversible redox system. Therefore, it can produce reactive oxygen species (ROS) and inhibit microsomal lipid peroxidation. It can be used in the study of tuberculosis and leprosy.